Study protocol: an open-label individually randomised controlled trial to assess the efficacy of artemether-lumefantrine prophylaxis for malaria among forest goers in Cambodia
Introduction In the Greater Mekong Subregion, adults are at highest risk for malaria. The most relevant disease vectors bite during daytime and outdoors which makes forest work a high-risk activity for malaria. The absence of effective vector control strategies and limited periods of exposure during...
Saved in:
| Main Authors: | Mavuto Mukaka, Naomi Waithira, Lorenz von Seidlein, Siv Sovannaroth, Richard James Maude, Rupam Tripura, Mom Ean, Meas Sokha, Thomas Julian Peto, James John Callery, Mallika Imwong, Ranitha Vongpromek, Joel Tarning, Oung Soviet |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-07-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/11/7/e045900.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antimalarial Drug Repurposing of Epirubicin and Pelitinib in Combination with Artemether and Lumefantrine
by: Douglas O. Ochora, et al.
Published: (2025-06-01) -
Possible treatment failure of artemether-lumefantrine in an Italian traveler with uncomplicated falciparum malaria.
by: Claudio Giacomazzi, et al.
Published: (2011-01-01) -
Possible treatment failure of artemether-lumefantrine in an Italian traveler with uncomplicated falciparum malaria.
by: Ernestina Carla Repetto, et al.
Published: (2011-10-01) -
Plasmodium falciparum and Schistosoma mansoni coinfection and the side benefit of artemether-lumefantrine in malaria patients
by: Solomon M Abay, et al.
Published: (2013-06-01) -
Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.
by: Frank Kloprogge, et al.
Published: (2018-06-01)